DPP4 and Hyperglycemia: It has been reported that the anti-diabetic drug dipeptidyl peptidase 4 inhibitor vildagliptin reduced the expression of DRP1 and Fis1, blocked the movement of DRP1 to the mitochondria, and slowed mitochondrial fragmentation induced by hyperglycemia [57].